EVAX Form 6-K: Press release on H2 2025 conference presentations

Rhea-AI Filing Summary

Evaxion A/S furnished a Form 6-K reporting that it issued a press release titled "Evaxion to present at several conferences during the second half of 2025" and furnished that press release as Exhibit 99.1 to the report. The company states this Form 6-K is incorporated by reference into multiple registration statements, including Forms S-8, F-3 and several Form F-1 filings, such that the press release and related disclosure become part of those registration statements to the extent not superseded. The report is signed on behalf of the registrant by Birgitte Rønø, Interim Chief Executive Officer.

Positive

• Press release furnished as Exhibit 99.1, confirming public disclosure of planned conference presentations during the second half of 2025
• Incorporation by reference into multiple registration statements (Forms S-8, F-3, and several F-1 filings), making the disclosure part of those filings

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine disclosure; the company furnished a press release about upcoming conference presentations and incorporated the report into its registration statements.

This filing is procedural: it furnishes a press release announcing planned presentations and formally incorporates the Form 6-K into specified registration statements. There are no financial results, transactions, or operational details in the filing itself. For investors, the filing confirms public dissemination of investor-facing events but contains no new quantitative metrics or material business changes.

Corporate Governance Expert

TL;DR: Administrative filing that documents a press release and proper signature by an authorized officer.

The form fulfills disclosure and incorporation-by-reference requirements and bears the signature of the Interim CEO. It does not disclose governance changes, executive appointments beyond the signature block, or material corporate actions. The filing adheres to routine reporting norms without providing additional substantive corporate information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 6-K: How Foreign Companies Report to the SEC →

Accepted by SEC EDGAR 08/27/2025 - 08:15 AM Learn about SEC filing dates

FAQ

What did Evaxion A/S (EVAX) disclose in this Form 6-K?

The company furnished a press release titled "Evaxion to present at several conferences during the second half of 2025" as Exhibit 99.1 and stated the report is incorporated by reference into specified registration statements.

Is there financial or operational data included in this Form 6-K for EVAX?

No. The filing contains no financial tables, earnings data, or details of material transactions; it furnishes a press release and incorporation language only.

Which registration statements does Evaxion incorporate this Form 6-K into?

The filing states incorporation by reference into Forms S-8, F-3, and several F-1 registration statements listed in the report.

Who signed the Form 6-K for Evaxion A/S?

The report is signed by Birgitte Rønø, Interim Chief Executive Officer.

Does this Form 6-K include the text of the press release?

The filing indicates the press release is furnished as Exhibit 99.1; the Form 6-K text provided here does not include the full press release body.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of August 2025

Commission File Number: 001-39950

Evaxion A/S
(Exact Name of Registrant as Specified in Its Charter)

Dr. Neergaards Vej 5f
DK-2970 Hoersholm
Denmark
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F [ X ]      Form 40-F [   ]

INCORPORATION BY REFERENCE

This report on Form 6-K shall be deemed to be incorporated by reference in Evaxion A/S’s registration statements on Form S-8 (File No. 333-255064), on Form F-3 (File No. 333-265132), on Form F-1, as amended (File No. 333-266050), Form F-1 (File No. 333-276505), Form F-1 (File No. 333-279153), Form F-1 (File No. 333-283304), and Form F-3 (File No. 333- 285778), including any prospectuses forming a part of such registration statements and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

Press Release

On August 27, 2025, Evaxion A/S (the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, issued a press release titled "Evaxion to present at several conferences during the second half of 2025". A copy of the press release is furnished as Exhibit 99.1 to this report on Form 6-K.

Exhibits

Exhibit No.		Description
99.1		Evaxion to present at several conferences during the second half of 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			Evaxion A/S
			(Registrant)
Date: August 27, 2025		By:	/s/ Birgitte Rønø
			Birgitte Rønø
			Interim Chief Executive Officer